Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q3 2014 · 10-Q
Revenue$633.20K$633.20K−31.7% vs Q3 2013 Net Income-$3.65M-$3.65MN/M vs Q3 2013 EPS Diluted$0.00$0.00N/M vs Q3 2013 Operating Income-$2,618,323N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,181,398N/M Margins · derivedOperating margin-413.5%−212.8 pt vs Q3 2013
Net margin-576.0%−231.5 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 14, 2014 · 45 d after period end